Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.42), $0.09 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $23.65 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.